TKNO RSI Chart
Last 7 days
9.8%
Last 30 days
-24%
Last 90 days
-43.1%
Trailing 12 Months
4.4%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 39.4M | 39.2M | 36.7M | 36.7M |
2022 | 39.0M | 42.3M | 43.6M | 41.4M |
2021 | 32.7M | 34.1M | 35.5M | 36.9M |
2020 | 0 | 0 | 0 | 31.3M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 30, 2023 | gelhaus ken | bought | 6,219 | 1.734 | 3,587 | chief commercial officer |
Nov 14, 2023 | hood lisa | sold | - | - | -15,000 | chief people officer |
Sep 19, 2023 | mackowski j matthew | bought | 1,500,000 | 1.85 | 810,810 | - |
Sep 19, 2023 | telegraph hill partners iv, l.p. | bought | 2,202,000 | 1.85 | 1,190,270 | - |
Sep 19, 2023 | telegraph hill partners iv, l.p. | bought | 12,798,000 | 1.85 | 6,917,840 | - |
Sep 19, 2023 | terrill damon | bought | 49,999 | 1.85 | 27,027 | general counsel and cco |
Sep 19, 2023 | gunstream stephen | bought | 99,999 | 1.85 | 54,054 | president and ceo |
Sep 19, 2023 | lowell matthew | bought | 99,999 | 1.85 | 54,054 | chief financial officer |
Aug 31, 2023 | mcnamara robert | back to issuer | - | - | -18,815 | - |
Jun 13, 2023 | hood lisa | sold | -43,267 | 3.7954 | -11,400 | chief people officer |
Which funds bought or sold TKNO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 01, 2024 | CONCOURSE FINANCIAL GROUP SECURITIES, INC. | sold off | - | - | - | -% |
Apr 26, 2024 | Conestoga Capital Advisors, LLC | added | 0.98 | -260,918 | 662,365 | 0.01% |
Apr 25, 2024 | Fielder Capital Group LLC | unchanged | - | -45,197 | 110,900 | 0.05% |
Apr 24, 2024 | BROWN ADVISORY INC | unchanged | - | -12,024 | 29,502 | -% |
Mar 11, 2024 | VANGUARD GROUP INC | reduced | -2.00 | 348,192 | 1,470,830 | -% |
Feb 15, 2024 | JANE STREET GROUP, LLC | new | - | 38,911 | 38,911 | -% |
Feb 14, 2024 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | unchanged | - | 65,800 | 261,100 | 0.01% |
Feb 14, 2024 | Balyasny Asset Management L.P. | reduced | -1.95 | 924,888 | 3,900,340 | 0.01% |
Feb 14, 2024 | MILLENNIUM MANAGEMENT LLC | added | 2.6 | 1,830,030 | 6,753,180 | -% |
Unveiling Alpha Teknova, Inc.'s Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Alpha Teknova, Inc.)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
JNJ | 357.8B | 85.6B | 9.3 | 4.18 | ||||
MRK | 330.2B | 61.4B | 143.19 | 5.38 | ||||
AMGN | 161.1B | 29.5B | 42.82 | 5.46 | ||||
PFE | 156.8B | 46.5B | -112.94 | 3.37 | ||||
GILD | 81.5B | 27.1B | 14.39 | 3.01 | ||||
TEVA | 15.6B | 15.8B | -27.14 | 0.99 | ||||
MID-CAP | ||||||||
ALKS | 4.2B | 1.7B | 9.58 | 2.41 | ||||
PRGO | 4.1B | 4.6B | -533.77 | 0.9 | ||||
BHC | 2.7B | 9.0B | -5.97 | 0.3 | ||||
AMPH | 2.1B | 644.4M | 14.96 | 3.19 | ||||
SMALL-CAP | ||||||||
TLRY | 1.5B | 743.2M | -4.38 | 2.07 | ||||
TXMD | 23.2M | 1.3M | -2.26 | 17.8 | ||||
ACRX | 17.0M | - | -0.92 | 0.22 | ||||
AGRX | 2.7M | 19.6M | -0.19 | 0.14 | ||||
ACOR | 1.1M | 117.6M | 0 | 0.01 |
Alpha Teknova, Inc. News
Income Statement (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Revenue | -3.7% | 7,867,000 | 8,169,000 | 11,527,000 | 9,121,000 | 7,891,000 | 10,692,000 | 11,690,000 | 11,147,000 | 10,110,000 | 9,392,000 | 8,313,000 | 9,078,000 | 9,031,000 | 8,984,000 | 6,044,000 |
Gross Profit | -9.3% | 1,335,000 | 1,472,000 | 5,066,000 | 2,423,000 | 2,110,000 | 4,770,000 | 5,247,000 | 5,349,000 | 4,979,000 | 4,263,000 | 3,354,000 | 5,025,000 | - | 5,088,000 | 3,469,000 |
Operating Expenses | 19.1% | 12,193,000 | 10,234,000 | 12,063,000 | 11,369,000 | 16,346,000 | 27,724,000 | 11,873,000 | 11,192,000 | 9,745,500 | 8,151,000 | 5,880,000 | 5,853,000 | - | 2,936,000 | 2,765,000 |
S&GA Expenses | -0.5% | 2,401,000 | 2,412,000 | 2,174,000 | 2,343,000 | 2,559,000 | 2,397,000 | 2,598,000 | 1,597,000 | 1,283,000 | 885,000 | 904,000 | 705,000 | - | 558,000 | 481,000 |
R&D Expenses | -6.2% | 1,311,000 | 1,397,000 | 1,464,000 | 1,395,000 | 1,870,000 | 1,925,000 | 1,929,000 | 2,013,000 | 1,389,500 | 1,372,000 | 851,000 | 700,000 | - | 358,000 | 341,000 |
EBITDA Margin | 10.7% | -0.88 | -0.98 | -1.25 | -1.23 | -1.11 | -0.85 | -0.44 | -0.39 | -0.28 | 0.19 | 0.20 | 0.21 | 0.22 | - | - |
Interest Expenses | 121.9% | 173,000 | -791,000 | -308,000 | 93,000 | 128,000 | 70,000 | 28,000 | -13,000 | -36,500 | -255,000 | -304,000 | 7,000 | - | 19,000 | - |
Income Taxes | -3477.8% | -304,000 | 9,000 | 15,000 | -18,000 | -786,000 | -374,000 | -400,000 | -400,000 | -1,205,500 | -892,000 | -600,000 | -165,000 | - | 636,000 | 200,000 |
Earnings Before Taxes | -8.0% | -10,960,000 | -10,144,000 | -7,139,000 | -8,835,000 | -14,089,000 | -22,848,000 | -6,598,000 | -5,856,000 | -4,841,000 | -4,143,000 | -2,833,000 | -820,000 | - | 2,169,000 | 723,000 |
EBT Margin | 7.7% | -1.01 | -1.10 | -1.35 | -1.33 | -1.19 | -0.92 | -0.51 | -0.45 | -0.34 | 0.13 | 0.14 | 0.14 | 0.15 | - | - |
Net Income | -5.0% | -10,656,000 | -10,153,000 | -7,154,000 | -8,817,000 | -13,294,000 | -22,474,000 | -6,203,000 | -5,497,000 | -3,647,000 | -3,251,000 | -2,250,000 | -655,000 | - | 1,533,000 | 512,000 |
Net Income Margin | 6.6% | -1.00 | -1.07 | -1.32 | -1.29 | -1.15 | -0.87 | -0.44 | -0.38 | -0.27 | 0.10 | 0.10 | 0.11 | 0.11 | - | - |
Free Cashflow | 40.2% | -3,204,000 | -5,354,000 | -6,194,000 | -11,996,000 | -12,759,000 | -14,914,000 | -16,758,000 | -11,118,000 | -10,494,000 | -8,744,000 | -8,225,000 | -1,483,000 | - | - | - |
Balance Sheet | |||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2020Q4 |
Assets | -7.1% | 129 | 138 | 133 | 141 | 152 | 160 | 182 | 184 | 167 | 169 | 173 | 63.00 |
Current Assets | -10.6% | 46.00 | 51.00 | 43.00 | 50.00 | 61.00 | 70.00 | 80.00 | 92.00 | 101 | 111 | 118 | 16.00 |
Cash Equivalents | -11.2% | 29.00 | 32.00 | 24.00 | 30.00 | 42.00 | 50.00 | 65.00 | 76.00 | 88.00 | 98.00 | 108 | 3.00 |
Inventory | 1.1% | 12.00 | 11.00 | 12.00 | 12.00 | 12.00 | 10.00 | 8.00 | 6.00 | 5.00 | 4.00 | 4.00 | 4.00 |
Net PPE | -2.4% | 50.00 | 52.00 | 53.00 | 54.00 | 52.00 | 53.00 | 47.00 | 37.00 | 30.00 | 22.00 | 18.00 | 10.00 |
Goodwill | - | - | - | - | - | - | - | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 | 17.00 |
Liabilities | -0.5% | 39.00 | 39.00 | 46.00 | 49.00 | 52.00 | 48.00 | 49.00 | 46.00 | 23.00 | 23.00 | 24.00 | 11.00 |
Current Liabilities | 6.4% | 9.00 | 8.00 | 29.00 | 9.00 | 11.00 | 12.00 | 12.00 | 13.00 | 8.00 | 6.00 | 6.00 | 4.00 |
Long Term Debt | 0.6% | 13.00 | 13.00 | - | 22.00 | 22.00 | 17.00 | 17.00 | 12.00 | 12.00 | 12.00 | 12.00 | - |
LT Debt, Current | - | - | - | 22.00 | - | - | - | - | - | - | - | - | - |
LT Debt, Non Current | -100.0% | - | 13.00 | - | - | 22.00 | - | - | - | - | - | - | - |
Shareholder's Equity | -9.6% | 90.00 | 100 | 86.00 | 92.00 | 100 | 112 | 133 | 139 | 143 | 146 | 149 | 17.00 |
Retained Earnings | -13.2% | -91.79 | -81.10 | -70.98 | -63.82 | -55.01 | -41.71 | -19.24 | -13.03 | -7.54 | -3.89 | -0.64 | 2.00 |
Additional Paid-In Capital | 0.6% | 182 | 181 | 157 | 156 | 155 | 154 | 153 | 152 | 151 | 150 | 150 | 14.00 |
Shares Outstanding | 0.2% | 41.00 | 41.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 28.00 | 12.00 | 4.00 | 4.00 |
Float | - | - | - | 19.00 | - | - | - | 59.00 | - | - | - | 164 | - |
Cashflow (Quarterly) | ||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 |
Cashflow From Operations | 34.0% | -2,892 | -4,382 | -3,856 | -7,684 | -8,029 | -8,332 | -5,838 | -5,201 | -3,082 | -4,837 | -3,551 | 2,401 | - | - | - |
Share Based Compensation | -1.3% | 1,022 | 1,035 | 1,070 | 1,010 | 1,022 | 968 | 934 | 787 | 624 | 442 | 302 | 183 | - | - | - |
Cashflow From Investing | 88.2% | -115 | -972 | -2,338 | -4,312 | -4,730 | -6,582 | -10,920 | -5,917 | -7,412 | -3,907 | -4,674 | -1,528 | - | - | - |
Cashflow From Financing | -104.6% | -621 | 13,625 | -180 | -25.00 | 5,140 | 35.00 | 5,037 | 55.00 | -1.00 | -1,265 | 101,781 | 10,278 | - | - | - |
Statements of Operations - USD ($) $ in Thousands | 12 Months Ended | |
---|---|---|
Dec. 31, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||
Revenue | $ 36,684 | $ 41,420 |
Cost of sales | 26,388 | 23,944 |
Gross profit | 10,296 | 17,476 |
Operating expenses: | ||
Research and development | 5,567 | 7,737 |
Sales and marketing | 9,330 | 9,151 |
General and administrative | 25,450 | 28,298 |
Amortization of intangible assets | 1,148 | 1,148 |
Goodwill impairment | 0 | 16,613 |
Tradename impairment | 2,169 | 0 |
Long-lived assets impairment | 2,195 | 4,188 |
Total operating expenses | 45,859 | 67,135 |
Loss from operations | (35,563) | (49,659) |
Other (expenses) income, net | ||
Interest (expense) income, net | (833) | 213 |
Other income, net | 142 | 55 |
Loss on extinguishment of debt | (824) | 0 |
Total other (expenses) income, net | (1,515) | 268 |
Loss before income taxes | (37,078) | (49,391) |
Benefit from income taxes | (298) | (1,923) |
Net loss | $ (36,780) | $ (47,468) |
Earnings Per Share [Abstract] | ||
Basic | $ (1.16) | $ (1.69) |
Diluted | $ (1.16) | $ (1.69) |
Weighted Average Number of Shares Outstanding, Basic and Diluted [Abstract] | ||
Basic | 31,819,776 | 28,083,563 |
Diluted | 31,819,776 | 28,083,563 |
Balance Sheets - USD ($) $ in Thousands | Dec. 31, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 28,484 | $ 42,236 |
Accounts receivable, net of allowance for doubtful accounts of $20 thousand and $22 thousand | 3,948 | 4,261 |
Inventories, net | 11,594 | 12,247 |
Income taxes receivable | 0 | 22 |
Prepaid expenses and other current assets | 1,634 | 2,374 |
Total current assets | 45,660 | 61,140 |
Property, plant and equipment, net | 50,364 | 51,577 |
Operating lease right-of-use assets | 16,472 | 19,736 |
Intangible assets, net | 14,239 | 17,556 |
Other non-current assets | 1,852 | 2,252 |
Total assets | 128,587 | 152,261 |
Current liabilities: | ||
Accounts payable | 1,493 | 2,449 |
Accrued liabilities | 5,579 | 6,203 |
Current portion of operating lease liabilities | 1,803 | 2,223 |
Total current liabilities | 8,875 | 10,875 |
Deferred tax liabilities | 919 | 1,223 |
Other accrued liabilities | 102 | 191 |
Long-term debt | 13,251 | 21,976 |
Long-term operating lease liabilities | 15,404 | 18,111 |
Total liabilities | 38,551 | 52,376 |
Stockholders’ equity: | ||
Preferred stock, $0.00001 par value, 10,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, zero shares issued and outstanding at December 31, 2023 and December 31, 2022 | 0 | 0 |
Common stock, $0.00001 par value, 490,000,000 shares authorized at December 31, 2023 and December 31, 2022, respectively, 40,727,780 and 28,179,423 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively | 0 | 0 |
Additional paid-in capital | 181,822 | 154,891 |
Accumulated deficit | (91,786) | (55,006) |
Total stockholders’ equity | 90,036 | 99,885 |
Total liabilities and stockholders equity | $ 128,587 | $ 152,261 |
 | Mr. Stephen Gunstream |
---|---|
 | teknova.com |
 | Pharmaceuticals |
 | 285 |